Found: 16
Select item for more details and to access through your institution.
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e315, doi. 10.1016/j.clml.2023.07.002
- By:
- Publication type:
- Article
Treatment Individualization in Diffuse Large B-Cell Lymphoma: Is Frailty Enough for Old Adults? An Original Article.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e348, doi. 10.1016/j.clml.2023.06.010
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions | From Biology to Therapy: Progress in Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. 705, doi. 10.1016/j.clml.2023.06.006
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions: Updates on BTK Inhibitors for the Treatment of Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. 697, doi. 10.1016/j.clml.2023.07.011
- By:
- Publication type:
- Article
Role of Rituximab in Treatment of Patients With Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. 733, doi. 10.1016/j.clml.2023.06.008
- By:
- Publication type:
- Article
Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. 719, doi. 10.1016/j.clml.2023.05.008
- By:
- Publication type:
- Article
Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e341, doi. 10.1016/j.clml.2023.07.006
- By:
- Publication type:
- Article
Factors Influencing Physician Discretion to Administer CNS Prophylaxis in Diffuse Large B Cell Lymphoma: A Single Institution Retrospective Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. 764, doi. 10.1016/j.clml.2023.06.009
- By:
- Publication type:
- Article
Multiple Myeloma in Adolescent and Young Adults: An ASCO CancerLinQ and SEER Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e335, doi. 10.1016/j.clml.2023.07.005
- By:
- Publication type:
- Article
Low-Dose Dasatinib (50 mg Daily) Frontline Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: 5-Year Follow-Up Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. 742, doi. 10.1016/j.clml.2023.05.009
- By:
- Publication type:
- Article
Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e360, doi. 10.1016/j.clml.2023.06.011
- By:
- Publication type:
- Article
Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. 749, doi. 10.1016/j.clml.2023.06.003
- By:
- Publication type:
- Article
Real-World Experience With CPX-351 Treatment for Acute Myeloid Leukemia in England: An Analysis From the National Cancer Registration and Analysis Service.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e323, doi. 10.1016/j.clml.2023.07.003
- By:
- Publication type:
- Article
Effect of the Presence of t(11;14) for Patients With AL Amyloidosis Treated With Bortezomib-Containing Regimens: Experience From the Amyloidosis Program of Calgary.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e331, doi. 10.1016/j.clml.2023.07.004
- By:
- Publication type:
- Article
Cross-Study Comparisons of JAK2 Inhibitors in Myelofibrosis: Risks and Recommendations.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. 714, doi. 10.1016/j.clml.2023.06.004
- By:
- Publication type:
- Article
CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. 772, doi. 10.1016/j.clml.2023.05.007
- By:
- Publication type:
- Article